Dimple Modi | Toxicology | Best Researcher Award

Investigator/Principal Scientist at GlaxoSmithKline, United States 🎓

Dimple Modi is an accomplished scientific leader with over 12 years of experience in pharmaceutical research and formulation development. Specializing in dermatology/topical and parenteral applications, Modi has a proven track record in leading cross-functional teams, optimizing drug formulations, and advancing projects from conceptualization to late-stage development. With expertise in regulatory compliance, project management, and innovative drug delivery systems, Modi is known for fostering innovation and driving successful drug development initiatives.

Professional Profile 

🎓Education🧑‍🎓

Dimple Modi earned a PhD in Pharmaceutical Science from Saint Joseph’s University (formerly University of the Sciences) in Philadelphia, PA, where their research focused on enhancing the oil solubility of BCS Class II drugs and increasing drug loading in nanoemulsions. Modi also holds a Master of Science in Pharmaceutical Manufacturing Practices from Stevens Institute of Technology in Hoboken, NJ, and a Bachelor of Science in Pharmacy from L.M. College of Pharmacy in Ahmedabad, Gujarat, India.

💼Work Experience

Dimple Modi, in their role as Investigator, Drug Product Development at GlaxoSmithKline, has excelled in leading the development and optimization of long-acting injectable suspensions and parenteral solutions. Modi oversees clinical formulation strategies and project management from early to late phases, while pioneering innovative extemporaneous compounding methods. Previously, as a Senior Research Scientist at GlaxoSmithKline, Modi conducted pivotal pre-formulation studies and developed platform cream formulations using DOE methodologies. At Lupin Pharmaceuticals, Modi advanced dermatological semisolid dosage forms, managed technology transfers, and authored critical regulatory documentation. Their analytical expertise and adherence to cGMP and cGLP guidelines were honed during their tenure as an Analytical Scientist.

🔍Research Focus 

Dimple Modi’s research focuses on the development and optimization of drug formulations, particularly in dermatology and parenteral applications. Key areas include enhancing drug solubility, optimizing delivery systems, and advancing formulation strategies from lab-scale to pilot-scale manufacturing. Modi is known for innovative approaches in drug development and regulatory compliance.

🏆Awards and Honors

  • Exceptional Science Award (2018): Recognized for designing and developing a platform cream formulation that accelerated development timelines for dermatology products.
  • Multiple Bronze/Silver Awards: Received within GlaxoSmithKline for scientific accomplishments.
  • Successfully Achieved 14 ANDA Submissions and Approvals: Demonstrates significant contributions to regulatory achievements.
  • Leadership in Career Development: Actively involved in initiatives to enhance diversity and mentorship within the industry.

Conclusion

Dimple Modi’s impressive track record in pharmaceutical research, combined with leadership skills and recognized innovations, makes them a strong candidate for the “Best Researcher Award.” Their ability to drive forward complex projects, mentor future scientists, and contribute to significant advancements in drug development aligns well with the criteria for such an award. Enhancing visibility through publications and broader impact initiatives could further solidify their suitability for the award.

📖Publications : 

  1. Long acting injectables for the treatment of prostate cancer
    Modi, D., Hussain, M.S., Ainampudi, S., Prajapati, B.G.
    Journal of Drug Delivery Science and Technology, 2024, 100, 105996
  2. In situ evaluation of the impact of metformin or verapamil coadministration with vildagliptin on its regional absorption from the rabbit’s intestine
    Elmeniar, A.M., Osman, M.A., El-Gizawy, S.A., Haggag, Y.A., Tambuwala, M.M.
    Biopharmaceutics and Drug Disposition, 2024, 45(2), pp. 71–82
  3. Enhancing Oil Solubility of BCS Class II Drug Phenytoin Through Hydrophobic Ion Pairing to Enable High Drug Load in Injectable Nanoemulsion to Prevent Precipitation at Physiological pH With a Potential to Prevent Phlebitis
    Modi, D., Jonnalagadda, S., Campbell, G.A., Dalwadi, G.
    Journal of Pharmaceutical Sciences, 2023, 112(9), pp. 2427–2443
  4. Accelerate development of topical cream drug product using a common platform base formulation
    Modi, D., Sharma, H., Campbell, G.
    Pharmaceutical Development and Technology, 2020, 25(6), pp. 767–778
  5. Understanding the role of sodium lauryl sulfate on the biorelevant solubility of a combination of poorly water-soluble drugs using high throughput experimentation and mechanistic absorption modeling
    Bahr, M.N., Modi, D., Patel, S., Campbell, G., Stockdale, G.
    Journal of Pharmacy and Pharmaceutical Sciences, 2019, 22(1), pp. 221–246
Dimple Modi | Toxicology | Best Researcher Award

You May Also Like